No Shortcuts: Two Pathways To Building A Future For Huntington's Disease Research

One of the tenets of clinical research is that findings often result in more questions than answers, often leading to further solutions. For Huntington’s Disease, an inherited, neurodegenerative disorder identified in the 1800s, the journey towards understanding and treating this rare disease continues to be a methodical one. Dr. Ole Isacson highlights two pathways to ongoing research for this rare disease: building biomarkers and exploring gene therapy. Read about these pathways in the available article as well as potential detours that could delay or derail research momentum.

To learn more about Biorasi, visit their Clinical Leader page.